Duke Heart Failure Symposium: The Leading Edge of Heart Failure Management

Duke Heart Failure Symposium: The Leading Edge of Heart Failure Management is organized by Duke University School of Medicine and will be held on Oct 08, 2021.

Target Audience:
This program is designed to meet the continuing education (CE) needs of cardiologists, nurses, and other allied healthcare professionals involved in the treatment of heart failure patients.

CME Accreditation:
Category 1: Duke University Health System Department of Clinical Education and Professional Development designates this activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse CE: Duke University Health System Department of Clinical Education and Professional Development designates this activity for up to 3.75 credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.

OverView:
Heart failure is a rapidly growing clinical problem in the United States and worldwide. Heart failure is the most common discharge diagnosis among patients 65 and older in the United States. Epidemiologic projections suggest that the overall burden of heart failure care will continue to grow dramatically, with an expected increase in prevalence of 46% from 2012 to 2030, resulting in over 8 million adults living with heart failure. Heart failure is estimated to account for over 30 billion dollars per year of health care spending, and controlling costs and improving care of heart failure patients has been a major focus of health care reform in the United States.  Heart failure care includes appreciation for the genetic risk factors and social determinants of health as they differentially impact disease burden and risk for progression. Advanced forms of heart failure carry a mortality rate greater than that of most cancers. Thus, it is critically important to raise awareness and improve knowledge about the symptoms, diagnosis, newer therapeutic options and outcomes in heart failure. 

A variety of recent developments in the field of heart failure therapies, including novel drugs, new devices, and care innovations inform the current effort to improve heart failure education and refine approaches to disease management for clinicians. Physicians and other practitioners must be armed with the most up-to-date evidence to guide best treatments and improve the prognosis for patients with heart failure. 

Learning Objectives:
• Identify the role of clinical trials in the development of new heart failure therapies: Goals of current and future trial design and endpoints
• Discuss the role of emerging drug therapy for chronic heart failure with reduced ejection fraction, with focus on updated treatment paradigms and challenges (i.e. how to initiate, combine, or switch therapies to newer evidence-based treatments, which therapies to prioritize, defining optimal therapy in the current era)
• Review and discuss best practices for acute heart failure therapy, including acute treatment strategies to prevent rehospitalization and improve natural history of disease
• Discuss the role of interventional and device management in acute heart failure and care trends in a contemporary intensive care setting
• Recognize and address challenges in transition of care and improving care coordination
• Describe how to initiate and sustain an open access and medication titration clinic
• Identify advances in the management of patients with heart failure in the outpatient setting with utilization of ambulatory monitoring, wearable technologies, and electronic care systems